Pharmacogenomics for Your Practice – Online

PGx at Your Own Pace Practical Content for Clinical Application

Role-based discounts are available. Click Register to view


Empowering the Health Care TeamHarness the Future of PGx for PrescribingAt your own pace - practical content for clinical application

Pharmacogenomics (PGx), the study of how one’s genes may affect an individual’s response to medication, is an emerging field within patient care.  This online course uses over 50 engaging videos from Mayo Clinic experts to teach you how pharmacogenomics testing can make an impact in your practice.  Topics include fundamentals of pharmacogenomics, how to interpret test results yourself, and tips on how to implement pharmacogenomics into your practice.  Learn through case studies and listen as expert panels debate controversial questions about the field.  Includes over 16 hours of content that you can go through at your own pace at work, at home, and even on your mobile device!

Jennifer A. Bold, APRN, C.N.P., D.N.P. - Course DirectorJennifer A. Bold, APRN, C.N.P., D.N.P.
Family Medicine
Jyothsna (Jo) Giri - Course Director

Jyothsna (Jo) Giri, M.D., M.B.A.
Center for Individualized Medicine

Christopher B. Grilli, Pharm.D., R.Ph., M.B.A. - Course Director

Christopher B. Grilli, Pharm.D., R.Ph., M.B.A.
Pharmacy

Wayne (Nick) T. Nicholson, M.D., Pharm.D. - Course DirectorWayne (Nick) T. Nicholson, M.D., Pharm.D.
Department of Anesthesiology

Target Audience

This activity has been designed for pharmacists, physicians, nurse practitioners, physician assistants, nurses, students, and other members of the health care team.

Learning Objectives

Upon completion of this course, participants should be able to:

  • Describe what to consider when implementing pharmacogenomics in clinical practice
  • Apply pharmacogenomics test results to make recommendations for an individualized medication management plan
  • Identify barriers and challenges of considering pharmacogenomics in patient care

Participation in this Mayo Clinic course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.

Additional Information

AttachmentSize
Additional Information96.2 KB
Course summary
Available credit: 
  • 16.00 ACPE
  • 16.00 AMA PRA Category 1 Credit
  • 16.00 ANCC
  • 16.00 Attendance
Course opens: 
11/01/2019
Course expires: 
10/31/2022
Cost:
$1,099.00

Pharmacogenomics Certificate Course

Pharmacogenomics (PGx) Principles and Concepts

Pharmacogenomics 101: An Introduction to Foundational Concepts
Christopher T. Grilli, Pharm.D., R.Ph., M.B.A.

Pharmacogenomics: Discovery and Translation
Liewei Wang, M.D., Ph.D.

Pharmacogenomics’ Emerging Role
Richard Weinshilboum, M.D.

Variability and Pharmacokinetic Principles
Wayne T. Nicholson, M.D., Pharm.D.

PGx from a Patient Perspective: GINA & Other Important Questions
Teresa M. Kruisselbrink, M.S., CGC, LCGC

Legal Implications of Pharmacogenomics Testing
Sharon C. Zehe, J.D.

Pharmacogenomics from the Patient Perspective: Panel Discussion
Darryl S. Chutka, M.D. (Moderator), Matthew J. Ferber, Ph.D., Karen M. Meagher, Ph.D. & Sharon C. Zehe, J.D.

Clinical Laboratory Testing in PGx: “the Lab” 101
Ann M. Moyer, M.D., Ph.D.

Clinical Laboratory Testing in PGx: Targeting Genotyping Technology
Ann M. Moyer, M.D., Ph.D.

Clinical Laboratory Testing in PGx: “Sequencing”
Ann M. Moyer, M.D., Ph.D.

Clinical Laboratory testing in PGx: “Reporting”
Ann M. Moyer, M.D., Ph.D.

Pharmacogenomics Application

Pharmacogenomics at the Clinic: Panel Discussion
Matthew E. Bernard, M.D., Jennifer A. Bold APRN, C.N.P., D.N.P., Darryl S. Chutka, M.D. (Moderator) & Paul Y. Takahashi, M.D.

Pharmacogenomics Testing: Role in Clinical Medicine
Denise M. Dupras, M.D., Ph.D.

Utilizing National Pharmacogenomics Guidelines and Other Resources
Jessica A. Wright, Pharm.D., R.Ph.

Pharmacogenomics: Case-Based Application

Pharmacogenomics of Analgesics
Wayne (Nick) T. Nicholson, M.D., Pharm.D.

Pharmacogenomics: Anesthesia
Timothy B. Curry, M.D., Ph.D.

Pharmacogenomics of Antidepressants
Adrijana Kekic, Pharm.D., R.Ph.

Case Review, SSRIs (Sertraline) and SNRIs
Adrijana Kekic, Pharm.D., R.Ph.

Psychiatric Pharmacogenomics: Panel Discussion
Darryl S. Chutka, M.D. (Moderator), Eric T. Matey, Pharm.D., R.Ph., Denise M. Dupras, M.D., Ph.D., Richard Weinshilboum, M.D.

Using Pharmacogenomics to Predict Drug Hypersensitivity
John D. Zeuli, Pharm.D., R.Ph.

Gout Management: Role of Pharmacogenomics
Denise M. Dupras, M.D., Ph.D.

HLA and Hypersensitivity: Carbamazepine
Jyothsna (Jo) Giri, M.D., M.B.A.

Pharmacogenomics in Cardiovascular Disease
Naveen L. Pereira, M.D.

Warfarin & Statin Pharmacogenomics Cases
Jan A. Anderson, Pharm.D., R.Ph.

Voriconazole
Christopher J. Arendt, Pharm.D., R.Ph.

Pharmacogenomics: Challenges with Liver & Hematopoietic Stem Cell Transplant
John Logan Black, M.D.

Pharmacogenomics for Transplant Patients: Immunosuppression and Beyond
Mira T. Keddis, M.D.

Polypharmacy and PGx: Multi-Drug, Herbal/Dietary Supplement Case Study
Michael J. Schuh, Pharm.D., R.Ph.

Case Study: Thiopourines/TPMT and NUDT15 in Clinical Practice
Edward V. Loftus, Jr. M.D.

PGx use in Patients with Gastroesophageal Reflux Disease
Imad Absah, M.D.

Dihydropyrimidine Dehydrogenase (DPD) Deficiency
Implications for 5-Fluorouracil (Capecitabine) Treatment
Robert B. Diasio, M.D.

Why is CYP2D6 Genotyping Ready for Primetime:
Association of CYP2D6 Genotype and Breast Cancer Outcome from Large Trials
Matthew P. Goetz, M.D.

Belinostate and UGT1A Polymorphism
N. Nora Bennani, M.D.

Case: Oncology
Caren L. Hughes, Pharm.D., R.Ph.

Pharmacogenomics in Oncology
Eric J. Yancey, Pharm.D., R.Ph.

Multi-Drug Phenoconversion Concept
Eric T. Matey, Pharm.D., R.Ph.

Pharmacogenomics at the Pharmacy: Panel Discussion
Christopher Grilli, Pharm.D., R.Ph.,M.B.A. (Moderator), Ashley D. Ebenhoh, Pharm.D., R.Ph.,
& Razan M. El Melik, Pharm.D., R.Ph.

Significant Pharmacogenomics Cases
Heather H. Randles, Pharm.D., R.Ph.

Case Review: From My Practice to Yours
Sheena K. Crosby, Pharm.D., R.Ph.

Pharmacogenomics Implementation

Sex, Drugs, and Genetic Variation
Ann M. Moyer, M.D., Ph.D.

10 Considerations for the Clinician Applying Pharmacogenomics to Practice
Wayne T. Nicholson, M.D., Pharm.D.

Education for the Multidisciplinary Team: Panel Discussion

Jyothsna (Jo) Giri, M.D., M.B.A., Christopher M. Kohler, M.A.N., R.N., N.E.-B.C., Tammy M. McAllister, M.A. (Moderator), & Lance J. Oyen, Pharm.D., R.Ph.

Developing an Individualized Medication Plan
Eric T. Matey, Pharm.D., R.Ph.

Imad Absah, M.D.
Pediatric Gastroenterology

Christopher M. Kohler, M.A.N., R.N., N.E.-B.C.
Nursing Administration

Jan A. Anderson, Pharm.D., R.Ph.
Medication Therapy Management

Teresa M. Kruisselbrink, M.S., CGC, LCGC
Center for Individualized Medicine

Christopher J. Arendt, Pharm.D., R.Ph.
Pharmacy

Konstantinos N. Lazaridis, M.D.
Gastroenterology
N. Nora Bennani, M.D.
Hematology
Edward V. Loftus, Jr. M.D.
Gastroenterology
Matthew E. Bernard, M.D.
Family Medicine

Eric T. Matey, Pharm.D., R.Ph.
Medication Therapy Management

John Logan Black, M.D.
Genomics
Tammy M. McAllister, M.A.
Center for Individualized Medicine
Jennifer A. Bold, APRN, C.N.P., D.N.P.
Family Medicine
Karen M. Meagher, Ph.D.
Biomedical Ethics
Sheena K. Crosby, Pharm.D., R.Ph.
Pharmacy
Ann M. Moyer, M.D., Ph.D.
Laboratory Medicine & Pathology
Timothy B. Curry, M.D., Ph.D.
Anesthesia
Wayne (Nick) T. Nicholson, M.D., Pharm.D.
Clinical Pharmacology
Robert B. Diasio, M.D.
Pharmacology - Cancer Center
Lance J. Oyen, Pharm.D., R.Ph.
Pharmacy
Denise M. Dupras, M.D., Ph.D.
Community Internal Medicine
Naveen L. Pereira, M.D.
Cardiovascular Medicine
Ashley D. Ebenhoh, Pharm.D., R.Ph.
Pharmacy
Heather H. Randles, Pharm.D., R.Ph.
Pharmacy
Razan M. El Melik, Pharm.D., R.Ph.
Pharmacy
Michael J. Schuh, Pharm.D., R.Ph.
Pharmacy
Matthew J. Ferber, Ph.D.
Center for Individualized Medicine
Paul Y. Takahashi, M.D.
Community Internal Medicine
Jyothsna (Jo) Giri, M.D.
Center for Individualized Medicine
Liewei Wang, M.D., Ph.D.
Schulze Center for Novel Therapeutics
Matthew P. Goetz, M.D.
Medical Oncology
Richard Weinshilboum, M.D.
Schulze Center for Novel Therapeutics
Christopher B. Grilli, Pharm.D., R.Ph., M.B.A.
Pharmacy

Jessica A. Wright, Pharm.D., R.Ph.
Pharmacy

Caren L. Hughes, Pharm.D., R.Ph.
Pharmacy
Eric J. Yancey, Pharm.D., R.Ph.
Pharmacy
Mira T. Keddis, M.D.
Nephrology
Sharon C. Zehe, J.D.
Legal Department
Adrijana Kekic, Pharm.D., R.Ph.
Pharmacy
John D. Zeuli, Pharm.D., R.Ph.
Medication Therapy Management

 

Accreditation Statement:


In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
 

Credit Statement(s):

AMA

Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 16.00 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

imageACPE
Mayo Clinic College of Medicine and Science designates this educational activity for a maximum of 16.00 ACPE Knowledge-based contact hours. Participants should claim only the credit commensurate with the extent of their participation in the activity.

ANCC
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 16.00 ANCC nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Other Healthcare Professionals
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

Available Credit

  • 16.00 ACPE
  • 16.00 AMA PRA Category 1 Credit
  • 16.00 ANCC
  • 16.00 Attendance

Accreditation Period

Course opens: 
11/01/2019
Course expires: 
10/31/2022

Price

Cost:
$1,099.00
Please login or create an account to take this course.

Full Fee: M.D., D.O., Ph.D.

$1099

Reduced Fee: NP, PA, Pharmacist

$799

Other Allied Health Professional

$599


Cancellation and Refund Policy:

Request for cancellations must be submitted in writing to cme@mayo.edu. 


Any use of this site constitutes your agreement to the Terms and Conditions of Online Registration.